Clinical trials
Phase 2/3 HIV Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 5 |
| 2009 | 5 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 4 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 47 |
| Terminated | 7 |
| Withdrawn | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centers for Disease Control and Prevention | 8 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| French National Agency for Research on AIDS and Viral Hepatitis | 4 |
| Gilead Sciences | 4 |
| ANRS, Emerging Infectious Diseases | 3 |
| PENTA Foundation | 3 |
| ViiV Healthcare | 3 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| Johns Hopkins University | 2 |
| AbbVie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HIV Infections | 65 |
| Acquired Immunodeficiency Syndrome | 12 |
| Hepatitis C | 4 |
| Tuberculosis | 4 |
| Inflammation | 3 |
| Cytomegalovirus Retinitis | 2 |
| Heroin Dependence | 2 |
| Lipodystrophy | 2 |
| Sexually Transmitted Diseases | 2 |
| AIDS Dementia Complex | 1 |
Trials
Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.